Kiadis Pharma

Developer of cell-based immunotherapy products for the treatment of blood cancers

placeAmsterdam, North Holland, Netherlands calendar_todayFounded 1997 groups103 employees language kiadis.com

Innovation

5 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 92 times.

YearFilings
20131
20161
20171
20181
20191
20202
20211
20231

Investor mix

9 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital444%
Private equity333%
Bank & private debt111%
Other / undisclosed111%
Coming soon